Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
45.05
+0.55 (1.25%)
At close: Dec 5, 2025
-18.31%
Market Cap 91.26B
Revenue (ttm) 40.94B
Net Income (ttm) 5.15B
Shares Out n/a
EPS (ttm) 2.53
PE Ratio 17.73
Forward PE 8.22
Dividend 2.22 (4.99%)
Ex-Dividend Date Oct 2, 2025
Volume 41
Average Volume 219
Open 45.00
Previous Close 44.50
Day's Range 44.98 - 45.00
52-Week Range 36.68 - 57.80
Beta n/a
RSI 72.16
Earnings Date Feb 5, 2026

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.